| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 118.3 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 118.3. The average price that BIM.PA shares were previous bought at was EUR 108.326. The current market price is 9.2% higher than average price they were purchased at. The value of the holding in BIM.PA has fallen by EUR 9,899 (USD $11,179) compared to the previous valuation of BioMerieux |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 44.13 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 44.13. The average price that FME.DE shares were previous bought at was EUR 44.4066. The current market price is -0.6% lower than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 35,931 (USD $40,576) compared to the previous valuation of Fresenius Medical Care AG |
| ZEAL.CO - | HOLD | 0 @ DKK 56.8438 | DKK 0 | The current share valuation price of ZEAL.CO based on adjusted close was DKK 56.8438. The average price that ZEAL.CO shares were previous bought at was DKK 83.2446. The current market price is -31.7% lower than average price they were purchased at. The value of the holding in ZEAL.CO has fallen by DKK 84,181 (USD $12,733) compared to the previous valuation of |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 50.54 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 50.54. The average price that ERF.PA shares were previous bought at was EUR 48.9498. The current market price is 3.2% higher than average price they were purchased at. The value of the holding in ERF.PA has fallen by EUR 11,442 (USD $12,921) compared to the previous valuation of Eurofins Scientific SE |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 214 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 214. The average price that SRT3.DE shares were previous bought at was EUR 222.106. The current market price is -3.6% lower than average price they were purchased at. The value of the holding in SRT3.DE has increased by EUR 244,830 (USD $276,478) compared to the previous valuation of Sartorius AG however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| SOBI.ST - | HOLD | 0 @ SEK 23.5769 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 23.5769. The average price that SOBI.ST shares were previous bought at was SEK 26.9845. The current market price is -12.6% lower than average price they were purchased at. The value of the holding in SOBI.ST has fallen by SEK 36,317 (USD $3,679) compared to the previous valuation of |
| GALD.SW - | HOLD | 0 @ CHF 84.412 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 84.412. The average price that GALD.SW shares were previous bought at was CHF 97.2295. The current market price is -13.2% lower than average price they were purchased at. The value of the holding in GALD.SW has fallen by CHF 74,084 (USD $90,262) compared to the previous valuation of |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 191.35 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 191.35. The average price that DIM.PA shares were previous bought at was EUR 187.348. The current market price is 2.1% higher than average price they were purchased at. The value of the holding in DIM.PA has increased by EUR 254,093 (USD $286,939) compared to the previous valuation of Sartorius Stedim Biotech however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 48.5 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 48.5. The average price that REC.MI shares were previous bought at was EUR 52.7232. The current market price is -8.0% lower than average price they were purchased at. The value of the holding in REC.MI has increased by EUR 7,630 (USD $8,616) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 49.34 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 49.34. The average price that ORNBV.HE shares were previous bought at was EUR 47.9229. The current market price is 3.0% higher than average price they were purchased at. The value of the holding in ORNBV.HE has fallen by EUR 29,590 (USD $33,415) compared to the previous valuation of Orion Oyj |
| RO.SW - | HOLD | 0 @ CHF 289.597 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 289.597. The average price that RO.SW shares were previous bought at was CHF 305.639. The current market price is -5.2% lower than average price they were purchased at. The value of the holding in RO.SW has fallen by CHF 32,584 (USD $39,699) compared to the previous valuation of |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 94.8 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 94.8. The average price that IPN.PA shares were previous bought at was EUR 109.524. The current market price is -13.4% lower than average price they were purchased at. The value of the holding in IPN.PA has fallen by EUR 77,770 (USD $87,823) compared to the previous valuation of Ipsen SA |
| HIK.L - | HOLD | 0 @ GBP 22.0217 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 22.0217. The average price that HIK.L shares were previous bought at was GBP 24.5528. The current market price is -10.3% lower than average price they were purchased at. The value of the holding in HIK.L has fallen by GBP 21,761 (USD $28,792) compared to the previous valuation of |
| DEMANT.CO - | HOLD | 0 @ DKK 29.9418 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 29.9418. The average price that DEMANT.CO shares were previous bought at was DKK 34.6261. The current market price is -13.5% lower than average price they were purchased at. The value of the holding in DEMANT.CO has fallen by DKK 21,939 (USD $3,318) compared to the previous valuation of |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 8.214 | EUR 0 | |
| AMP.MI - Amplifon SpA | HOLD | 0 @ EUR 16.36 | EUR 0 | The current share valuation price of AMP.MI based on adjusted close was EUR 16.36. The average price that AMP.MI shares were previous bought at was EUR 23.5373. The current market price is -30.5% lower than average price they were purchased at. The value of the holding in AMP.MI has fallen by EUR 23,175 (USD $26,171) compared to the previous valuation of Amplifon SpA |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 56.4086 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 56.4086. The average price that NOVO-B.CO shares were previous bought at was DKK 72.6601. The current market price is -22.4% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 923,405 (USD $139,666) compared to the previous valuation of Novo Nordisk A/S |
| COLO-B.CO - | HOLD | 0 @ DKK 94.0568 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 94.0568. The average price that COLO-B.CO shares were previous bought at was DKK 99.4698. The current market price is -5.4% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 413 (USD $62) compared to the previous valuation of |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 36.68 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 36.68. The average price that QIA.DE shares were previous bought at was EUR 36.5498. The current market price is 0.4% higher than average price they were purchased at. The value of the holding in QIA.DE has fallen by EUR 50,454 (USD $56,976) compared to the previous valuation of QIAGEN NV |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.4579 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.4579. The average price that HLN.L shares were previous bought at was GBP 4.68254. The current market price is -4.8% lower than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 137,144 (USD $181,455) compared to the previous valuation of Haleon PLC however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 20.955 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 20.955. The average price that BAYN.DE shares were previous bought at was EUR 21.037. The current market price is -0.4% lower than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 60,066 (USD $67,831) compared to the previous valuation of Bayer AG however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 97.4589 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 97.4589. The average price that NOVN.SW shares were previous bought at was CHF 97.8035. The current market price is -0.4% lower than average price they were purchased at. The value of the holding in NOVN.SW has increased by CHF 53,245 (USD $64,872) compared to the previous valuation of however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 119.413 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 119.413. The average price that AZN.L shares were previous bought at was GBP 130.736. The current market price is -8.7% lower than average price they were purchased at. The value of the holding in AZN.L has fallen by GBP 574,638 (USD $760,304) compared to the previous valuation of AstraZeneca PLC |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 90.39 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 90.39. The average price that SAN.PA shares were previous bought at was EUR 97.8777. The current market price is -7.7% lower than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 657,594 (USD $742,599) compared to the previous valuation of Sanofi SA |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 15.669 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 15.669. The average price that GSK.L shares were previous bought at was GBP 16.7685. The current market price is -6.6% lower than average price they were purchased at. The value of the holding in GSK.L has fallen by GBP 135,200 (USD $178,883) compared to the previous valuation of GlaxoSmithKline PLC |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 249.8 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 249.8. The average price that EL.PA shares were previous bought at was EUR 249.655. The current market price is 0.1% higher than average price they were purchased at. The value of the holding in EL.PA has fallen by EUR 195,804 (USD $221,115) compared to the previous valuation of EssilorLuxottica SA |
| LONN.SW - | HOLD | 0 @ CHF 583.504 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 583.504. The average price that LONN.SW shares were previous bought at was CHF 574.681. The current market price is 1.5% higher than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 8,741 (USD $10,650) compared to the previous valuation of |
| ALC.SW - | HOLD | 0 @ CHF 81.6 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 81.6. The average price that ALC.SW shares were previous bought at was CHF 82.745. The current market price is -1.4% lower than average price they were purchased at. The value of the holding in ALC.SW has increased by CHF 52,492 (USD $63,955) compared to the previous valuation of however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 523.4 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 523.4. The average price that ARGX.BR shares were previous bought at was EUR 575.954. The current market price is -9.1% lower than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 187,433 (USD $211,662) compared to the previous valuation of Argenx SE |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 138.4 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 138.4. The average price that UCB.BR shares were previous bought at was EUR 179.631. The current market price is -23.0% lower than average price they were purchased at. The value of the holding in UCB.BR has fallen by EUR 243,835 (USD $275,355) compared to the previous valuation of UCB SA |
| ROG.SW - | HOLD | 0 @ CHF 274.083 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 274.083. The average price that ROG.SW shares were previous bought at was CHF 289.065. The current market price is -5.2% lower than average price they were purchased at. The value of the holding in ROG.SW has fallen by CHF 564,329 (USD $687,560) compared to the previous valuation of |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 21.19 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 21.19. The average price that PHIA.AS shares were previous bought at was EUR 24.2436. The current market price is -12.6% lower than average price they were purchased at. The value of the holding in PHIA.AS has fallen by EUR 22,544 (USD $25,458) compared to the previous valuation of Koninklijke Philips NV |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 118.65 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 118.65. The average price that MRK.DE shares were previous bought at was EUR 136.276. The current market price is -12.9% lower than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 18,231 (USD $20,588) compared to the previous valuation of Merck KGaA |
| SDZ.SW - | HOLD | 0 @ CHF 35.6179 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 35.6179. The average price that SDZ.SW shares were previous bought at was CHF 39.7514. The current market price is -10.4% lower than average price they were purchased at. The value of the holding in SDZ.SW has fallen by CHF 94,595 (USD $115,252) compared to the previous valuation of |
| SOON.SW - | HOLD | 0 @ CHF 250.92 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 250.92. The average price that SOON.SW shares were previous bought at was CHF 301.597. The current market price is -16.8% lower than average price they were purchased at. The value of the holding in SOON.SW has fallen by CHF 42,036 (USD $51,215) compared to the previous valuation of |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 44.99 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 44.99. The average price that SHL.DE shares were previous bought at was EUR 51.351. The current market price is -12.4% lower than average price they were purchased at. The value of the holding in SHL.DE has increased by EUR 21,109 (USD $23,838) compared to the previous valuation of Siemens Healthineers AG however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 39.5 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 39.5. The average price that FRE.DE shares were previous bought at was EUR 35.7153. The current market price is 10.6% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 75,497 (USD $85,256) compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2025-04-16 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 172.942 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 172.942. The average price that GMAB.CO shares were previous bought at was DKK 195.655. The current market price is -11.6% lower than average price they were purchased at. The value of the holding in GMAB.CO has fallen by DKK 7,794 (USD $1,179) compared to the previous valuation of |
| STMN.SW - | HOLD | 0 @ CHF 102.889 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 102.889. The average price that STMN.SW shares were previous bought at was CHF 120.847. The current market price is -14.9% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 165,545 (USD $201,695) compared to the previous valuation of |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 11.4755 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 11.4755. The average price that SN.L shares were previous bought at was GBP 12.9824. The current market price is -11.6% lower than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 53,915 (USD $71,335) compared to the previous valuation of Smith & Nephew PLC |
| DIA.MI - DiaSorin SpA | SELL | -840 @ EUR 98.12 | EUR -82,421 | The ETF sold 840 shares of DIA.MI on 2025-04-16. The shares were previously bought for an average price of EUR 99.7953. The DiaSorin SpA shares were sold for -1.7% lower than average price of previous purchases. This resulted in an overall loss of EUR 1,407 (USD $1,589) The average price that the ETF previously sold DIA.MI share for is EUR 99.328 which is higher than the selling price of EUR 98.12 on 2025-04-16. |